➢ Participating in CRS➢ Inducing the expression of IL-1β and IL-6➢ Inducing T cell apoptosis➢ Neutrophil-mediated bronchial hyperresponsiveness and airway inflammation➢ Increasing disease severity➢ Decreasing the number of T cells. This evidence concerns the gene IL1B and inflammatory response.